Journal Reviews

Environmental variations in endophthalmitis

3 August 2023 | | Retina / Uvea / Vitreous | Endophthalmitis, anti-VEGF, climate, intravitreal injection, season

In this retrospective cohort study, the authors looked at seasonal and environmental variations in 171 endophthalmitis cases out of 423,297 intravitreal injections. The incidence of this complication was not correlated to monthly snowfall, rainfall, or average temperature. There was no...

ROP ocular outcomes after Bevacizumab treatment

1 October 2017 | | Paediatric Ophthalmology / Strabismus | Biometry, intravitreal injection, refraction, retinopathy of prematurity

The relationship between refractive outcomes and biometric parameters were evaluated following intravitreal Bevacizumab (IVB) monotherapy. Sixty-three infants were grouped into 1) infants treated with VB monotherapy for ROP (six with zone 1 and eight with posterior zone II retinopathy of...

Intravitreal injection related endophthalmitis

1 April 2015 | | Retina / Uvea / Vitreous | Age-related macular degeneration (AMD), endophthalmitis, intravitreal injection, post-injection complications, vascular endothelial growth factor (VEGF)

This article reviews the incidence, clinical findings, risk factors, management and visual outcomes in intravitreal injection related endophthalmitis. Incidence of this complication is reported to be in the range of 0.038% to 0.065% (1 in 2000-3000 injections). Patients present typically...